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Edited by David LambethAbstract Actin has been reported to enhance the superoxide-
generating activity of neutrophil NADPH oxidase in a cell-free
system and to interact with p47phox, a regulatory subunit of the
oxidase. In the present study, we searched for an actin-binding
site in p47phox by far-western blotting and blot-binding assays
using truncated forms of p47phox. The amino-acid sequence
319–337 was identiﬁed as an actin-binding site, and a synthetic
peptide of this sequence bound to actin. The sequence shows no
homology to other known actin-binding motifs. It is located in
the autoinhibitory region of p47phox and includes Ser-328, a
phosphorylation site essential for unmasking. Although a phos-
phorylation-mimetic p47phox mutant bound to actin with a lower
aﬃnity than the wild type, the same mutant interacted with ﬁla-
mentous actin more eﬃciently than the wild type. A mutant pep-
tide p47phox (319–337, Ser328Glu) bound to ﬁlamentous actin
more tightly than to monomer actin. These results suggest that
p47phox moves to cortical actin when it becomes unmasked in
the cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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polymerization1. Introduction
p47phox is a regulatory subunit of phagocyte NADPH oxi-
dase, which produces superoxide (O2 ) during phagocytosis
and plays a crucial role in host defense [1]. The oxidase is dor-
mant in resting cells, and becomes activated upon cell stimula-
tion through assembly of its catalytic and regulatory subunits
[2,3]. The catalytic core protein is the membrane ﬂavocyto-
chrome b558, consisting of p22
phox and gp91phox (Nox2), while
the regulatory subunits are p47phox, p67phox, rac and p40phox,
which are translocated from the cytosol to the membrane.
Although p47phox was ﬁrst discovered in phagocytes, subse-
quent studies have revealed that it is also expressed in
non-phagocytic cells. For example, p47phox activates Nox2 in
vascular endothelial cells with other regulatory subunits [4];Abbreviations: O2 , superoxide; AIR, autoinhibitory region; SDS,
sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis;
F-actin, ﬁlamentous actin; G-actin, globular actin
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doi:10.1016/j.febslet.2005.11.080p47phox also activates Nox1, a homolog of Nox2 [5], in vascu-
lar smooth muscle cells [6]. The reactive oxygen species pro-
duced in these cells may have other function than host
defense, such as redox regulation or cell proliferation [4,7].
p47phox is assumed to play as an adapter for organization of the
oxidase complex, since it reduces the required concentrations of
other subunits [8,9] and stabilizes the oxidase [10,11]. It has been
established that p47phox is intramolecularly masked through
interactions among its PX domain, SH3 domains and autoinhib-
itory region (AIR) [3]. After becoming unmasked by phos-
phorylation, p47phox interacts with p22phox, a subunit of ﬂavocy-
tochrome b558, thereby leading to activation of the oxidase
[12,13]. In addition, the PXdomain has been suggested to interact
with the plasma membrane through phosphoinositides [3]. These
concepts were recently conﬁrmed by structural studies [14].
Actin was originally discovered as a component of myoﬁ-
brils present in muscle cells (a-actin). The protein is also
known to be a component of the cytoskeleton in non-muscle
cells (mainly b-actin). In human neutrophils, actin is abun-
dantly present (30 lM) and one-third of it is polymerized
in the resting state [15]. Upon cell activation, more actin mol-
ecules become polymerized into ﬁlamentous actin (F-actin).
Several studies have demonstrated interactions between the
cytoskeleton and cytosolic components of NADPH oxidase
[16,17]. Furthermore, we previously found that actin enhances
the activation of neutrophil NADPH oxidase [18], and actin-
depolymerizing agents facilitated its deactivation in a cell-free
system [19]. Clements et al. [20] demonstrated that inhibition
of actin polymerization modulates the respiratory burst of neu-
trophils. Despite these lines of evidence, neither the role of ac-
tin ﬁlaments in regulating NADPH oxidase nor the
mechanisms for these phenomena have been well deﬁned.
In an attempt to clarify these points, we focused on the pro-
tein–protein interaction between p47phox and actin which we
previously found [21]. We searched for an actin-binding site
in the p47phox molecule, and based on the obtained result, we
then examined whether the interaction between p47phox and ac-
tin is inﬂuenced by the conformational change of p47phox by
unmasking or that of actin by polymerization.2. Materials and methods
2.1. Materials
Glutathione–Sepharose, CM–Sepharose, pGEX-6P and PreScission
Protease were purchased from Amersham Biosciences (Piscataway,
NJ). Oligonucleotide primers for mutagenesis were synthesized by
Amersham Biosciences or Sigma Genosys (St. Louis, MO). A Quik
Change mutagenesis kit was purchased from Stratagene (La Jolla,
CA). Diisopropyl ﬂuorophosphate was obtained from Wako Pureblished by Elsevier B.V. All rights reserved.
262 M. Tamura et al. / FEBS Letters 580 (2006) 261–267Chemicals (Osaka, Japan). A rabbit antibody against human actin
(residues 20–33) and streptavidin–agarose CL-4B were purchased from
Sigma–Aldrich (St. Louis, MO). An antibody against human p47phox
(C-terminal 13mer peptide) was a kind gift from Dr. David Lambeth
(Department of Pathology, Emory University School of Medicine,
Atlanta, GA). Biotinylated peptides LSQDAYRRNSVRFLQQRRR
and LSQDAYRRNEVRFLQQRRR (purity 97%) were synthesized
by Thermo Electron (Ulm, Germany).
2.2. Construction of plasmids for truncated forms of p47phox and a triple
mutant
A complementary DNA (cDNA) for human p47phox (in pVL1393)
was a kind gift from Dr. David Lambeth (Department of Pathology,
Emory University School of Medicine). The cDNA was ampliﬁed by
PCR using speciﬁc 5 0- and 3 0-primers with attached EcoRI site linkers
and then subcloned into pGEX-6P (EcoRI fragment). The p47phox
cDNA in pGEX-6P was then mutated to introduce a stop codon at
each designated site using a Quik Change mutagenesis kit. To con-
struct a p47phox triple mutant (Ser303/304/328Glu), the p47phox cDNA
was initially mutated to convert Ser-303 and -304 to Glu, and then fur-
ther mutated to convert Ser-328 to Glu using a Quik Change mutagen-
esis kit. The sequences of all the truncated forms and the triple mutant
were conﬁrmed by dideoxynucleotide-based sequencing.
2.3. Expression and puriﬁcation of the p47phox truncates and the triple
mutant
Expression and puriﬁcation of the truncated forms of p47phox were
performed as previously described for full-length p47phox [11]. After
expression, the cells were lysed in the presence of 0.2 mM diisopropyl
ﬂuorophosphate and puriﬁed with glutathione–Sepharose beads. Each
truncated form was released from the glutathione-S-transferase beads
by treatment with PreScission Protease at 4 C for 4 h. After centrifu-
gation, the precipitates were resuspended in the same buﬀer and incu-
bated for an additional 12 h. The fractions containing each truncated
form were combined, dialyzed against 20 mM potassium phosphate
buﬀer (pH 7.0) and concentrated with Ultrafree Biomax 30k (Milli-
pore, Bedford, MA). For the triple mutant or full-length p47phox, the
glutathione–Sepharose-puriﬁed fraction was applied to a CM–Sephar-
ose column equilibrated with 20 mM sodium phosphate buﬀer (pH 7.0)
containing 60 mM NaCl, and the column was eluted with a NaCl gra-
dient (60–200 mM) in the same buﬀer. The fractions containing the
protein were concentrated and dialyzed against 20 mM potassium
phosphate buﬀer (pH 7.0).
2.4. Construction of a plasmid containing human b-actin
A cDNA for human b-actin (in pHF) was a kind gift from Dr. Lau-
rence Kedes (Institute for Genetic Medicine, Southern California Uni-
versity School of Medicine, Los Angeles, CA). The cDNA was
ampliﬁed by PCR using speciﬁc 5 0 and 3 0-primers with an attached
BamHI and EcoRI site, respectively, and then subcloned into pGEX-
6P (BamHI and EcoRI fragment).
2.5. Expression and puriﬁcation of b-actin
The pGEX-6P containing the b-actin cDNA was transfected into
Escherichia coli BL-21 and expressed at 20 C for 20 h. Lysis and puri-
ﬁcation procedures were performed using our established procedures
(Tamura et al., manuscript in preparation). Brieﬂy, the cells were lysed
by sonication in the absence of DNase I, which tightly binds to actin.
The extracted protein was puriﬁed with glutathione–Sepharose beads,
and then further puriﬁed by a polymerization–depolymerization meth-
od [22]. The precipitate was dissolved in actin monomer buﬀer (buﬀer
G) (5 mM Tris–HCl, pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP, and
0.5 mMDTT) and dialyzed against the same buﬀer. The puriﬁed mono-
mer actin (G-actin) was lyophilized and stored at 20 C until use.
In some blot-binding assays, G-actin was polymerized by incubation
in polymerization buﬀer (buﬀer F) (5 mM Tris–HCl, pH 8.0, 50 mM
KCl, 2 mM MgCl2, 1 mM ATP, and 0.5 mM DTT) for 3 h at 4 C
and designated ‘‘F-actin’’.
2.6. Far-western blotting
Full-length or truncated forms of p47phox (0.1 nmol) were subjected
to sodium dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis
(PAGE) in a 12% gel and the protein bands were blotted onto aBA85 nitrocellulose membrane (Schleicher & Schuell, Dassel, Ger-
many). After checking proteins by Fast Green staining, the membrane
was blocked with buﬀer A (20 mM Tris–HCl, pH 7.4, 0.3 M NaCl, and
0.05% Tween 20) and incubated with b-actin (2 lM) at 4 C for 2 h.
After washing with buﬀer A, the membrane was treated with actin
IgG at 25 C for 12 h, and detected with peroxidase-conjugated goat
anti-rabbit IgG (Cappel Products, Irvine, CA). After color develop-
ment with 4-chloro-1-naphthol, the blots were scanned using an Epson
GT8700 scanner and analyzed with the NIH Image software.
2.7. Blot-binding assay
Full-length, truncated, or mutant forms of p47phox (0.1 nmol) were
directly applied to a nitrocellulose membrane using a dot-blotting
apparatus AE-6190 (Atto, Tokyo, Japan). After checking proteins by
Fast Green, the membrane was blocked and treated as described for
the far-western blotting.
2.8. Assay for O2 generation
Assay for O2 generation was performed as described previously [23].
The activation mixture contained p47phox or p47phox (S303/304/328E)
(1.3 lM), p67phox(1–210) (6 lM), racQ61L (6 lM), and puriﬁed cyto-
chrome b558 [11] (0.1 lM) in 50 ll of buﬀer A containing 4mMMgCl2,
10 lMFAD and 10 lMGTP. The mixture was incubated with 200 lM
SDS for 5 min at 25 C to activate NADPH oxidase. Four 10 ll ali-
quots of the activation mixture were transferred into the wells of a
96-well microplate and diluted with 240 ll of buﬀer B (20 mM potas-
sium phosphate buﬀer, pH 7.0, 4 mM MgCl2, and 10 lM FAD) con-
taining 200 lM NADPH and 80 lM cytochrome c. Superoxide
generation was measured by monitoring the cytochrome c reduction
at 550 nm using a Spectra Classic microplate reader (Tecan, Zurich,
Switzerland).3. Results
3.1. Truncated forms of p47phox
Our previous study revealed that p47N, p47phox (1–286),
does not bind to actin, thereby suggesting that the C-terminal
region of p47phox contains an actin-binding site [21]. To locate
this site, we prepared various C-terminally truncated forms of
p47phox and examined their interactions with actin. The struc-
tures of these truncated forms of p47phox are illustrated in
Fig. 1A. p47D1 (1–337) contained nearly all of the AIR and
terminated with a triad of arginine residues. p47D2 (1–330) ter-
minated at the basic sequence RRNSVR, containing Ser-328
for phosphorylation. p47D3 (1–318) terminated at another ba-
sic sequence, RSRKR. p47D4 (1–298) terminated before the
unique sequence PPRRSS, containing two serine residues for
phosphorylation. Finally, p47N (1–286) lacked the whole
AIR and the following region. An SDS–polyacrylamide gel
after electrophoresis of the puriﬁed truncated forms of p47phox
is shown in Fig. 1B. Each sample showed a single major band
at the position expected for its molecular weight.
3.2. Interactions between the truncated forms of p47phox and
actin
The interactions of the truncated forms of p47phox with b-
actin were examined by far-western blotting. p47phox and
its truncated mutants were electrophoresed in an SDS–
polyacrylamide gel and blotted onto a nitrocellulose mem-
brane. The membrane was incubated with human b-actin
and the bound protein was detected by actin IgG. Fig. 2 shows
typical results for this blotting analysis. The color development
was analyzed in several experiments and expressed as the %
intensity relative to that of full-length p47phox (Fig. 2B).
p47D1 showed a similar intensity to full-length p47phox, while
Fig. 1. Truncated forms of p47phox used in this study. (A) Schematic
illustrations of the truncated forms of p47phox. The domain structures
of p47D1, p47D2, p47D3, p47D4 and p47N are shown in comparison
with full-length p47phox. SH3: SH3 domain; AIR: autoinhibitory
region. (B) SDS–PAGE of the puriﬁed p47phox truncated forms. After
electrophoresis, the proteins were stained with Coomassie Brilliant
Blue. The expected molecular masses of p47D1, p47D2, p47D3, p47D4
and p47N are 39, 38, 37, 34 and 33 kDa, respectively.
Fig. 2. Interactions between the truncated forms of p47phox and actin
detected by far-western blotting. (A) Far-western blots. Full-length
and truncated forms of p47phox (0.1 nmol) were subjected to far-
western blotting analysis as described in Section 2. Protein bands
stained by Fast Green prior to actin treatment were shown in the upper
box. (B) Relative intensities. After color development, the membranes
were scanned and analyzed using the NIH Image software. The
intensities are expressed as percentages relative to that with full-length
p47phox. Data are expressed as the means ± S.D. of three to ﬁve
experiments.
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truncates p47D4 and p47N showed almost no color develop-
ment. These results demonstrate that the actin-binding ability
of the C-terminal region largely depends on the residues 319–
337 of p47phox.
3.3. Interaction of non-denatured p47phox truncates with actin
In far-western blotting, the capture proteins are denatured
during the procedure. To examine the interactions of the trun-
cated forms of p47phox in their native states, we performed
blot-binding assays. p47phox and its truncated forms were
directly blotted onto a nitrocellulose membrane and incubated
with actin. Typical results of the color development after
detection with actin IgG and a secondary antibody are shown
in Fig. 3A. Compared with full-length p47phox, the intensity of
p47D2 was apparently decreased and that of p47D3 was
further diminished. p47D4 and p47N showed almost no color
development. Image analysis of triplicate experiments revealed
that p47D1, p47D2, p47D3, p47D4 and p47N showed 88%,
58%, 24%, 4% and 2% of the intensity of full-length p47phox,
respectively. These results were essentially the same as those
obtained for the far-western blotting, although the % intensity
of p47D1 was slightly lower and that of p47D3 was slightly
higher. These slight diﬀerences may be due to conformational
diﬀerences between the native and denatured states of the
proteins. Based on these results, we identiﬁed the sequenceLSQDAYRRNSVRFLQQRRR (319–337) as an actin-binding
site.
3.4. Interaction of the peptide (319–337) with actin
To conﬁrm the above result, a biotinylated peptide with the
corresponding sequence was synthesized (Fig. 4A), and its
interaction with actin was examined by a blot-binding assay
(Fig. 4B). An apparent colored spot was obtained in the assay
indicating that the peptide had the ability to bind actin. We
further performed the experiment with various concentrations
of the peptide or full-length p47phox to estimate the binding
aﬃnities. The EC50 of p47
phox was estimated to be 1.7 lM,
while that of the peptide was estimated to be 2.7 lM (Table
1). The slightly weaker binding aﬃnity of the peptide may sug-
gest that another part of p47phox also contributes to its actin-
binding ability. Further studies are required to clarify this
point.
3.5. A phosphorylation-mimetic mutant of p47phox
The AIR is involved in the self-masking of p47phox and its
phosphorylation-induced unmasking leads to activation of
NADPH oxidase. Therefore, to examine whether the interac-
tion is inﬂuenced by the conformational change of p47phox, a
Fig. 3. Interactions between non-denatured p47phox truncated forms
and actin detected by blot-binding assay. (A) Dot-blots. Full-length
and truncated forms of p47phox (0.1 nmol) were subjected to blot-
binding assay as described in Section 2. Protein spots stained by Fast
Green prior to actin treatment were shown in the upper box. (B)
Relative intensities. After color development, the membranes were
scanned and analyzed using the NIH Image software. Data are
expressed as the means ± S.D. of three to ﬁve experiments.
Fig. 4. Interaction between the p47phox fragment (319–337) and actin
detected by blot-binding assay. (A) Structure of the N-terminally
biotinylated synthetic peptide (319–337). (B) Blot-binding assay. Actin
(0.1 nmol) was applied to a nitrocellulose membrane. The membrane
was incubated with biotinylated peptide (319–337) (10 lM) or 20 mM
potassium phosphate buﬀer (pH 7.0). After washing, the bound
peptide was detected with peroxidase-conjugated streptavidin. Protein
spots stained by Fast Green prior to target treatment were shown in
the upper boxes.
Table 1
Actin-binding aﬃnities of full-length p47phox and its actin-binding
fragment
p47phox Residues EC50 (lM)
Full-length 1–390 1.7 ± 0.2
Fragment 319–337 2.7 ± 0.2
Actin (0.1 nmol) was applied to a nitrocellulose membrane. After
blocking, the membrane was incubated with p47phox or biotinylated
p47phox (319–337) peptide at various concentrations. After washing,
the spots were treated with p47phox IgG followed by secondary anti-
body treatment or with peroxidase-conjugated streptavidin. After
color development, the blots were analyzed using the NIH software
and the EC50 values were estimated by ﬁtting the average intensities
from three determinants to the Michaelis–Menten equation.
Fig. 5. Eﬀect of a phosphorylation-mimetic p47phox mutant on
NADPH oxidase activation in the absence of SDS. (A) Schematic
illustration of the phosphorylation-mimetic p47phox (S303/304/328E)
mutant. PX and PR represent the PX domain and proline-rich region,
respectively. The hatched bar shows the location of the actin-binding
site. (B) O2 -generating activity of the oxidase reconstituted with wild-
type or mutant p47phox. The cell-free activation mixture contained
p47phox or p47phox (S303/304/328E), p67phox(1–210), racQ61L and
ﬂavocytochrome b558 with (light gray) or without (dark gray) SDS in
50 ll of buﬀer B. Data are expressed as the means ± S.D. of four
experiments.
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Glu) [24], was prepared (Fig. 5A). The mutant p47phox acti-
vated NADPH oxidase in a pure cell-free system withoutSDS to 61% of the full activity while the wild type showed only
negligible activity (9%) (Fig. 5B), indicating that the mutant
has an open structure as suggested in a previous report using
a similar triple mutant in a crude cell-free system containing
the plasma membrane [24].
A blot-binding assay revealed that the mutant p47phox inter-
acted with G-actin (monomer actin) less eﬀectively than the
wild type (Table 2). On the other hand, the mutant interacted
with F-actin (polymerized actin) more tightly than the wild-
type p47phox. Consequently, the mutant had a 3-fold higher
Table 2
Eﬀects of p47phox unmasking and/or actin polymerization on the
interaction with actina
Actin form Blot-binding assay (% intensity)b
p47phox p47phox (S303/304/328E)
G-actin 100 55.2 ± 6.4
F-actin 100.5 ± 4.9 143.2 ± 18.5
aG- or F-actin (0.1 nmol) was applied to a nitrocellulose membrane.
After blocking, the membrane was incubated with wild-type p47phox or
p47phox (S303/304/328E) (20 lM) at 4 C for 2 h. After washing, the
bands were treated with p47phox IgG for 12 h at 25 C, and then de-
tected with peroxidase-conjugated anti-rabbit IgG. After color devel-
opment, the blots were analyzed as described for Table 1.
bThe color intensities are expressed as percentages relative to that for
wild-type p47phox and G-actin.
M. Tamura et al. / FEBS Letters 580 (2006) 261–267 265aﬃnity for F-actin than for G-actin. This result demonstrates
that p47phox favors F-actin over G-actin when it becomes un-
masked.
3.6. Interaction of the mutant peptide (S328E) with G- and
F-actin
As the peptide(319–337) contains Ser-328, a possible phos-
phorylation site, we also synthesized a phosphorylation-
mimetic mutant, the peptide(S328E), and examined its
interaction with G- and F-actin by pull-down and blot-binding
assay. Pull-down assay showed that both G- and F-actin were
pulled down by the mutant peptide bound to streptavidin–aga-
rose (Fig. 6A), indicating that the peptide interacts with both
G- and F-actin. In this system, however, we cannot compare
the strength of the interactions because some molecules in F-Fig. 6. Interaction of the mutant peptide p47phox (319–337, S328E)
with G- and F-actin. (A) Pull-down assay G- or F-actin (2 lM) was
mixed with the mutant peptide (20 lM) in 100 ll of buﬀer G or buﬀer
F, respectively, and incubated for 2 h at 4 C. Streptavidin–agarose
(14 ll of 50% slurry) was added, and the mixture was rotated slowly
for 30 min at room temperature. After centrifugation at 2000 rpm for
1 min at 4 C, the supernatant was taken up and the pellets were
washed with buﬀer G or buﬀer F, respectively, and then centrifuged
again. After removing supernatant, the pellet was dissolved in SDS-
sample buﬀer and subjected to SDS–PAGE. (B) Blot-binding assay. G-
actin or F-actin (0.2 nmol) was blotted on a nitrocellulose membrane
and the mutant peptide (20 lM) was used as target protein. Other
conditions were as described for Fig. 4.actin might be pulled down with an adjacent molecule that
bound to the peptide. Therefore, we next performed blot-bind-
ing assay using the mutant peptide as a target (Fig. 6B). The
result clearly showed that F-actin bound the mutant peptide
more tightly than G-actin. This is consistent with the result
with the triple mutant of whole p47phox (Table 2).4. Discussion
Regarding the molecular interaction of the NADPH oxidase
with actin, we previously found that a component of the oxi-
dase p47phox directly binds to actin [21]. The results of that
study also revealed that the binding site is located in the C-ter-
minal region of p47phox. Therefore, the initial aim of the pres-
ent study was to locate the actual actin-binding site in p47phox.
Various C-terminally truncated forms of p47phox were con-
structed and examined for their interactions with actin by far-
western blotting and blot-binding assays. As a result, we iden-
tiﬁed a 19-residue sequence, LSQDAYRRNSVRFLQQRRR
(319–337), as an actin-binding motif in the C-terminal region
of p47phox. This sequence is located in the AIR of p47phox,
and includes Ser-328 which is phosphorylated during in vivo
activation [3]. The phosphorylation of Ser-328 and other spe-
ciﬁc serine residues is thought to induce p47phox unmasking,
thereby leading to interaction with p22phox, a subunit of ﬂavo-
cytochrome b558[3]. Therefore, we next examined whether or
not the interaction is inﬂuenced by unmasking of p47phox.
The experiment with an open-form, phosphorylation-mimetic
mutant, p47phox(Ser303/304/328Glu) [24], demonstrated that
the interaction became weaker when p47phox was unmasked
(Table 1).
Since cellular actin polymerizes upon cell activation, our
next question was whether the interaction is inﬂuenced by ac-
tin polymerization. Using polymerized actin (F-actin) in blot-
binding assays, we found that the binding with F-actin was
rather enhanced by unmasking. This result, together with the
above observation, indicates that the open form of p47phox fa-
vors F-actin by 3-fold (Table 2). In consistent with the concept,
a phosphorylation-mimetic mutant of the peptide (319–337)
interacted more tightly with F-actin than with G-actin
(Fig. 6). These ﬁndings are quite interesting considering that
actin polymerization occurs upon cell activation and the
oxidase complex simultaneously assembles on the plasma
membrane.
The newly identiﬁed sequence shows no homology with
other known actin-binding motifs, suggesting that it represents
a novel actin-binding motif. Homology searches of databases
produced several proteins with homologous sequences. Among
these, PLC-c1 appears to be particularly interesting, since it is
already known to bind the actin cytoskeleton [25]. The homol-
ogous sequence in PLCc1 is LSQVNYRVPNMRFLRERLT
(residues 181–199) (underlines and double-underlines indicate
homologous and identical residues, respectively). This site is
possibly involved in the actin-binding of PLC-c1, although
only its SH2 region has been deﬁned as an actin-binding site
to date [26]. It is tempting to speculate that the new actin-bind-
ing motif is also functional in other actin-binding proteins.
Further studies are required to clarify this point.
What is the biological relevance of the current ﬁndings?
First, the present results suggest that p47phox is already associ-
ated with actin in the resting cytosol. This is likely because the
266 M. Tamura et al. / FEBS Letters 580 (2006) 261–267EC50 value of p47
phox for actin was 1.7 lM and the cellular
concentration of p47phox in neutrophils is more than 6 lM
[27]. The idea is also supported by our preliminary data show-
ing that a well-known 240-kDa complex consisting of p47phox
and other cytosolic factors [28] also contained actin in the
cytosol (unpublished result). Second, since p47phox in the open
form favored F-actin over G-actin, it may move to cortical ac-
tin, i.e., actin ﬁlaments formed beneath the plasma membrane,
when it becomes unmasked. Cortical actin binds to ERM pro-
teins (ezrin, radixin, moesin) which are linked to CD44 or
other integral membrane proteins. Therefore, it appears that
cortical actin serves as an anchor for the oxidase to the mem-
brane, and p47phox as a connector that links the oxidase and
the anchor. The concept provides a possible mechanism for
the involvement of actin ﬁlaments in the oxidase activation
[19,20].
In a previous study, we found that actin enhances the activa-
tion of the NADPH oxidase in a crude cell-free system [18].
Therefore, here we examined if the peptide (319–337) impairs
the actin-enhanced activation of the oxidase. However, we
actually found that the peptide inhibited the oxidase activation
itself (data not shown), so we could not deﬁne if the peptide
interfere with the actin enhancement of the oxidase activation.
The mechanism for the inhibition will be another subject to be
clariﬁed.
Regarding interactions between p47phox and the plasma
membrane, it has been reported that the PX domain interacts
with the membrane through phosphoinositides [3]. Meanwhile,
Wientjes et al. demonstrated that the PX domain of p47phox
interacts with moesin directly [29], and Zhan et al. proposed
that the interaction may contribute to the p47phox transloca-
tion to the membrane [30]. It remains unclear which interac-
tion is more important for the translocation of p47phox to the
membrane. Perhaps, multiple interactions that are diﬀerently
regulated might be involved in the event. Further studies are
required to clarify this issue.
In the present study, we exclusively used b-actin in the exper-
iments, as this is the major actin isoform in phagocytes. How-
ever, in vascular smooth muscle cells, the major isoform is
a-actin being a component of the sarcomere. In the muscle
cells, p47phox activates Nox1, which may be involved in cell
proliferation and occasionally in hypertrophy and hyperten-
sion. Therefore, the interaction between p47phox and a-actin
ﬁlaments may be another interesting subject for investigation
in relation to the function of Nox1.
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